For those who choose to vaccinate their horses themselves, EQUI-JEC vaccines bring Boehringer Ingelheim quality and safety in an over-the-counter vaccine portfolio that protects against a variety of common equine infectious diseases.
EQUI-JEC vaccines protect against multiple diseases in one convenient, pre-filled syringe.
Safety studies of 880 horses showed 98% were reaction-free after two doses of EQUI-JEC 7.1
EQUI-JEC vaccines offer effective infectious disease protection from a variety of diseases.
For those who choose to vaccinate their horses themselves, EQUI-JEC offers a variety of protection options against Eastern encephalomyelitis (EEE), Western encephalomyelitis (WEE), Venezuelan encephalomyelitis (VEE), West Nile virus (WNV), tetanus, influenza and herpesvirus.
Find EQUI-JEC vaccines online or at your local retailer.
Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1-mL dose. Administer a second 1-mL dose intramuscularly in 3 to 4 weeks using a different injection site. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
Precautions: Store at 35-46ºF (1-8ºC). Do not freeze. Do not mix with other products. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.
See product insert for administration information.
EQUI-JEC 7 has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against Eastern, Western, and Venezuelan encephalomyelitis (EEE, WEE, VEE), West Nile virus (WNV), and tetanus, and against respiratory disease due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4) and equine influenza virus (EIV). The duration of immunity against EIV is at least 6 months and against WNV is at least 12 months. The duration for the remaining organisms has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.
This product has also been shown to be effective against shedding due to EIV and against viremia, mortality, and neurologic clinical disease due to WNV.
Composition: Contains Kentucky lineage (KY/95), Florida sublineage clade 1 (OH/03) and Eurasian Newmarket/2/93 (NM 2/93) EIV strains. Amphotericin B and gentamicin added as preservatives.
1 USDA Summary of Studies
EQUI-JEC® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. ©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0105-2024
